Serum Bactericidal Test
Blood Bactericidal Activity
Streptococcus
Serum
Stachybotrys
Trichophyton
Cladosporium
Tinea
Alternaria
Trichothecenes
Fungi
The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent. (1/129)
The in-vitro activity of HMR 3647, a novel ketolide, was investigated in comparison with those of erythromycin A, roxithromycin, clarithromycin (14-membered ring macrolides), amoxycillin-clavulanate and ciprofloxacin against 719 recent clinical Gram-positive, Gram-negative and anaerobic isolates and type cultures. HMR 3647 generally demonstrated greater activity than the other compounds with MIC90s of < or =0.5 mg/L, except for Staphylococcus epidermidis (MIC90 > 128 mg/L), Haemophilus influenzae (MIC90 = 2 mg/L), Enterococcus faecalis (MIC90 = 2 mg/L), Enterococcus faecium (MIC90 = 1 mg/L) and the anaerobes, Bacteroides fragilis (MIC90 = 2 mg/L) and Clostridium difficile (MIC90 = 1 mg/L). In general, an increase in the size of the inoculum from 10(4) to 10(6) cfu on selected strains had little effect on the MICs of HMR 3647. Additionally, the in-vitro activity of HMR 3647 was not affected by the presence of either 20 or 70% (v/v) human serum. The antichlamydial activity of HMR 3647 was generally greater than that of commonly used antichlamydial antimicrobials. (+info)Bactericidal properties of moxifloxacin and post-antibiotic effect. (2/129)
The time-kill kinetics and post-antibiotic effect (PAE) of moxifloxacin were studied for strains of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus and Escherichia coli. Moxifloxacin had a bactericidal effect against all strains tested, with the least rapid bactericidal effect being against S. pyogenes and the most rapid effect against S. aureus and E. coli. The PAE of moxifloxacin was similar to that of other fluoroquinolones and increased with increasing concentration. No association was found between the bactericidal effect of moxifloxacin and the duration of PAE. Gram-positive and gram-negative organisms were also exposed to concentrations of moxifloxacin, sparfloxacin and amoxycillin that simulated the drug concentrations obtained in human serum after standard oral dosing schedules. Simulation of moxifloxacin concentrations in human serum reduced viable counts more effectively and more rapidly than shown in time-kill experiments; in contrast, sparfloxacin and amoxycillin were less effective than when constant concentrations of these antibacterials were used. (+info)Pharmacodynamics of fluoroquinolones. (3/129)
Fluctuating concentrations of three fluoroquinolones (moxifloxacin, sparfloxacin and ofloxacin) and a beta-lactam (amoxycillin) were used in vitro to simulate antibiotic concentrations in human serum after oral doses of antibiotics. The antibiotics were tested against Staphylococcus aureus 12241 and Streptococcus pneumoniae 4241. Moxifloxacin and sparfloxacin were also tested against Escherichia coli Neumann. Human serum concentrations of moxifloxacin and ciprofloxacin were also simulated in an in-vivo murine thigh muscle model against S. aureus, S. pneumoniae and E. coli. Ciprofloxacin, sparfloxacin and ofloxacin had a dose-independent effect on gram-positive organisms beyond their optimal dose that gave a maximum effect, as did amoxycillin. In contrast, moxifloxacin had a dose-dependent and therefore concentration-dependent effect on both gram-positive and beta-lactam-susceptible and-resistant gram-negative organisms. The marked activity of moxifloxacin against both gram-positive and gram-negative organisms was confirmed in an in-vivo model. A human dose equivalent of 200 mg moxifloxacin reduced viable counts of S. pneumoniae below the limit of detection and regrowth did not occur. S. aureus was eliminated almost as effectively as S. pneumoniae. A 200 mg dose of moxifloxacin completely eliminated the original inoculum of E. coli within 6 h. Treatment of S. aureus with ciprofloxacin (250 or 500 mg) resulted in a dose-independent decrease in viable counts by approximately 3.5 log10 cfu/mL. A 125 mg dose of ciprofloxacin almost completely eliminated the original inoculum of E. coli within 8 h, whereas both the 250 mg and 500 mg doses reduced viable counts below the limit of detection. Thus, the in-vitro and in-vivo pharmacodynamic models used in this study established that moxifloxacin was highly effective against both gram-negative and gram-positive bacteria. (+info)Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae. (4/129)
The objective of this study was to determine the serum bactericidal activity (SBA) of levofloxacin against Streptococcus pneumoniae strains with various degrees of susceptibility to penicillin and cefotaxime. Serum samples of volunteers (n = 12) who had received levofloxacin 500 mg as a single po dose were provided in blinded fashion. SBA was determined, using the microdilution method, in Todd-Hewitt broth supplemented with lysed horse blood inoculated with an overnight culture diluted to yield a final concentration of approximately 10(5) cfu/mL. The serum bactericidal titre was defined as the highest dilution of serum showing no growth (> 99.9% reduction of inoculum). The duration of SBA ranged from 0.75 to 6.3 h (mean 3.85 h), and was independent of the susceptibility of the strains to penicillin and cefotaxime. In conclusion, a single po dose of 500 mg levofloxacin achieved serum concentrations which were bactericidal against penicillin-resistant S. pneumoniae for a mean period of 3.85 h. (+info)Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates. (5/129)
The aim of this study was to assess the serum bactericidal activity (SBA) of levofloxacin compared with that of ofloxacin against methicillin-resistant Staphylococcus aureus (MRSA) isolates. Serum from 10 healthy volunteers (seven females, three males) was collected after a single oral dose of either levofloxacin (500 mg) or ofloxacin (400 mg). Subjects were allocated randomly to treatment after at least a 1 week interval between antibiotic regimens. Three well-defined MRSA strains were tested, each susceptible to levofloxacin and ofloxacin, with different levels of resistance to methicillin (HBD 456, HBD 3 and HBD 2; class 1, 2 and 3 Tomasz heterogeneous resistance, respectively) together with a methicillin-susceptible (MSSA) reference strain (S. aureus ATCC 25,923). SBA was tested in vitro by a microtitration method 15 min before dosing and at 1, 4, 8 and 12 h after drug absorption. Levofloxacin was significantly more bactericidal than ofloxacin against all strains of S. aureus tested (SBA > or = 1:2). An SBA was recorded for only a short period with ofloxacin, and thereafter only bacteriostatic activity remained. This study, therefore, confirms the superior activity of levofloxacin over that of ofloxacin against MSSA and MRSA. (+info)Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in-vitro model simulating serum pharmacokinetic parameters. (6/129)
The objective of the current study was to evaluate the bactericidal activity of levofloxacin against Streptococcus pneumoniae at concentrations equivalent to those present in serum after a po dosage of 500 mg. Nine S. pneumoniae strains (one penicillin G-resistant, one penicillin G-intermediate resistant, and two penicillin G- and cefotaxime-resistant) were exposed to a levofloxacin concentration of 6 mg/L diluted at a terminal half-life (t1/2) of 8 h. Surviving S. pneumoniae (cfu/mL) were quantified up to 24 h by the membrane filtration method. Levofloxacin was rapidly bactericidal and reduced the quantity of inoculum to below the detection level of 10 cfu/mL within 2.5-5.15 h, irrespective of susceptibility to penicillin G or cefotaxime. No viable S. pneumoniae could be detected at the end of the observation period (24 h). All strains except one (strain 17134) had an MIC < 1.0 mg/L, and the minimum bactericidal concentrations (MBCs) were, at the most, one dilution higher than the respective MICs. The inoculum was high, ranging from 2.9 x 10(5) to 7.5 x 10(6) cfu/mL. The time required to achieve 99% death ranged from 0.9 to 3.1 h, and was longest for strain 17134 which had an MIC of 1.0 mg/L and an MBC of 2.0 mg/L. A 99.9% reduction in inoculum was achieved within 1.5-4.15 h. At a serum concentration achievable after a single po dosage of 500 mg, levofloxacin showed rapid and complete bactericidal activity against the S. pneumoniae strains tested. (+info)Serum bactericidal and inhibitory titres in the management of melioidosis. (7/129)
A retrospective evaluation of the relationship between serum bactericidal and inhibitory titres and treatment outcome in 195 adult Thai patients with severe melioidosis was conducted. Drug regimens included ceftazidime (52% of patients), co-amoxiclav (24%), imipenem (11%) or the conventional four-drug combination (11%). Pre- and 1 h post-dose serum samples were collected after 48-72 h of therapy, and serum inhibitory and bactericidal titrations determined. Median post-dose titres were: bactericidal 1:8 (range 0-1:128) and inhibitory 1:16 (range 0-1:128). Overall mortality was 26% and outcome was not influenced by either inhibitory or bactericidal titres. Pre-dose titres correlated with renal function; renal function was the most important predictor of mortality. Determination of serum inhibitory or bactericidal titres is unhelpful in the management of severe melioidosis. (+info)Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables. (8/129)
A randomized open-label study was conducted to compare the pharmacokinetics and pharmacodynamics of grepafloxacin with those of clarithromycin in patients with chronic bronchitis whose sputa were colonized with potential bacterial pathogens. Patients received oral grepafloxacin 400 mg od for 10 days (n = 15) or oral clarithromycin 500 mg bd for 10 days (n = 10). Sputum samples were collected before the first dose, 1, 4 and 8 h after a dose on day 1 and then before a dose on days 2, 3, 5, 7 and 10 to determine the time to eradication (T(erad)) of the potential bacterial pathogens. Blood samples for measurement of grepafloxacin or clarithromycin and 14-hydroxyclarithromycin concentrations were obtained before a dose and 1, 2, 4, 8 and 12 h after doses on days 1 and 5. The area under the inhibitory serum concentration-time curve over 24 h (AUIC(24)), peak serum concentration:MIC ratio (C(max):MIC) and the percentage of the dosing interval during which the serum concentration exceeded the MIC (%tau >MIC) were calculated and serum inhibitory titres (SITs) were determined. Haemophilus spp. were the predominant potential bacterial pathogens and were recovered from the sputa of 24 patients. Strains of Streptococcus pneumoniae were isolated from two patients in the grepafloxacin group and a strain of Moraxella catarrhalis was isolated from one patient in the clarithromycin group. Haemophilus spp. isolates were eradicated from the sputa of 13 of 14 (93%) patients given grepafloxacin, but from only two of 10 (20%) patients given clarithromycin (P < 0.05). In the other eight (80%) patients who received clarithromycin, the sputum cultures remained positive throughout the 10 day course. Grepafloxacin eliminated potential bacterial pathogens more quickly than clarithromycin (median T(erad) 4 h versus 76 h). The S. pneumoniae strains were eradicated by grepafloxacin within 4 h and the single M. catarrhalis strain was eradicated by clarithromycin within 1 h. The greater efficacy of grepafloxacin, compared with that of clarithromycin, in terms of the incidence and speed of eradication of the Haemophilus spp. isolates, was associated with higher median values of AUIC(24) (169 SIT(-1)*h versus 8.1 SIT(-1)*h), C(max):MIC ratio (23.6 versus 0.7) and %tau >MIC (100% versus 0%). A Hill-type model adequately described the relationship between the percentage probability of eradicating potential bacterial pathogens from sputa and the plasma grepafloxacin concentration. (+info)A Serum Bactericidal Test (SBT) is a laboratory test used to determine the ability of a patient's serum to kill specific bacteria. The test measures the concentration of complement and antibodies in the serum that can contribute to bacterial killing. In this test, a standardized quantity of bacteria is mixed with serial dilutions of the patient's serum and incubated for a set period. After incubation, the mixture is plated on agar media, and the number of surviving bacteria is counted after a suitable incubation period. The bactericidal titer is defined as the reciprocal of the highest dilution of serum that kills 99.9% of the initial inoculum.
The SBT is often used to evaluate the efficacy of antibiotic therapy, assess immune function, and diagnose infections caused by bacteria with reduced susceptibility to complement-mediated killing. The test can also be used to monitor the response to immunotherapy or vaccination and to identify patients at risk for recurrent infections due to impaired serum bactericidal activity.
It is important to note that the SBT has some limitations, including its variability between laboratories, the need for specialized equipment and expertise, and the potential for false-positive or false-negative results. Therefore, the test should be interpreted in conjunction with other clinical and laboratory data.
Blood bactericidal activity refers to the ability of an individual's blood to kill or inhibit the growth of bacteria. This is an important aspect of the body's immune system, as it helps to prevent infection and maintain overall health. The bactericidal activity of blood can be influenced by various factors, including the presence of antibodies, white blood cells (such as neutrophils), and complement proteins.
In medical terms, the term "bactericidal" specifically refers to an agent or substance that is capable of killing bacteria. Therefore, when we talk about blood bactericidal activity, we are referring to the collective ability of various components in the blood to kill or inhibit the growth of bacteria. This is often measured in laboratory tests as a way to assess a person's immune function and their susceptibility to infection.
It's worth noting that not all substances in the blood are bactericidal; some may simply inhibit the growth of bacteria without killing them. These substances are referred to as bacteriostatic. Both bactericidal and bacteriostatic agents play important roles in maintaining the body's defense against infection.
Streptococcus is a genus of Gram-positive, spherical bacteria that typically form pairs or chains when clustered together. These bacteria are facultative anaerobes, meaning they can grow in the presence or absence of oxygen. They are non-motile and do not produce spores.
Streptococcus species are commonly found on the skin and mucous membranes of humans and animals. Some strains are part of the normal flora of the body, while others can cause a variety of infections, ranging from mild skin infections to severe and life-threatening diseases such as sepsis, meningitis, and toxic shock syndrome.
The pathogenicity of Streptococcus species depends on various virulence factors, including the production of enzymes and toxins that damage tissues and evade the host's immune response. One of the most well-known Streptococcus species is Streptococcus pyogenes, also known as group A streptococcus (GAS), which is responsible for a wide range of clinical manifestations, including pharyngitis (strep throat), impetigo, cellulitis, necrotizing fasciitis, and rheumatic fever.
It's important to note that the classification of Streptococcus species has evolved over time, with many former members now classified as different genera within the family Streptococcaceae. The current classification system is based on a combination of phenotypic characteristics (such as hemolysis patterns and sugar fermentation) and genotypic methods (such as 16S rRNA sequencing and multilocus sequence typing).
Serum, in the context of clinical and medical laboratory science, refers to the fluid that is obtained after blood coagulation. It is the yellowish, straw-colored liquid fraction of whole blood that remains after the clotting factors have been removed. Serum contains various proteins, electrolytes, hormones, antibodies, antigens, and other substances, which can be analyzed to help diagnose and monitor a wide range of medical conditions. It is commonly used for various clinical tests such as chemistry panels, immunological assays, drug screening, and infectious disease testing.
Stachybotrys is a genus of filamentous fungi (molds) that are known to produce potent mycotoxins, which can be harmful to humans and animals. The most well-known species is Stachybotrys chartarum, commonly referred to as "black mold" or "toxic black mold." This mold typically grows on materials with high cellulose content and a low nitrogen content, such as paper, straw, hay, wet drywall, and ceiling tiles. Exposure to the mycotoxins produced by Stachybotrys can cause various health issues, including respiratory symptoms, allergic reactions, and immune system responses. It is essential to address water damage and mold growth promptly to prevent the spread of Stachybotrys and other molds in indoor environments.
Trichophyton is a genus of fungi that are primarily responsible for causing various superficial and cutaneous infections in humans and animals. These infections, known as dermatophytoses or ringworm, typically involve the skin, hair, and nails. Some common examples of diseases caused by Trichophyton species include athlete's foot (T. rubrum), jock itch (T. mentagrophytes), and scalp ringworm (T. tonsurans).
The fungi in the Trichophyton genus are called keratinophilic, meaning they have a preference for keratin, a protein found in high concentrations in skin, hair, and nails. This characteristic allows them to thrive in these environments and cause infection. The specific species of Trichophyton involved in an infection will determine the clinical presentation and severity of the disease.
In summary, Trichophyton is a medical term referring to a group of fungi that can cause various skin, hair, and nail infections in humans and animals.
'Cladosporium' is a genus of fungi that are widely distributed in the environment, particularly in soil, decaying plant material, and indoor air. These fungi are known for their dark-pigmented spores, which can be found in various shapes and sizes depending on the species. They are important causes of allergies and respiratory symptoms in humans, as well as plant diseases. Some species of Cladosporium can also produce toxins that may cause health problems in susceptible individuals. It is important to note that medical definitions typically refer to specific diseases or conditions that affect human health, so 'Cladosporium' itself would not be considered a medical definition.
Tinea is a common fungal infection of the skin, also known as ringworm. It's called ringworm because of its characteristic red, circular, and often scaly rash with raised edges that can resemble a worm's shape. However, it has nothing to do with any kind of actual worm.
The fungi responsible for tinea infections belong to the genus Trichophyton, Microsporum, or Epidermophyton. These fungi thrive in warm, damp environments and can be contracted from infected people, animals, or contaminated soil. Common types of tinea infections include athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm of the scalp (tinea capitis).
Treatment for tinea typically involves antifungal medications, either topical or oral, depending on the location and severity of the infection. Proper hygiene and avoiding sharing personal items can help prevent the spread of this contagious condition.
'Alternaria' is a genus of widely distributed saprophytic fungi that are often found in soil, plant debris, and water. They produce darkly pigmented, septate hyphae and conidia (asexual spores) that are characterized by their distinctive beak-like projections.
Alternaria species can cause various types of plant diseases, including leaf spots, blights, and rots, which can result in significant crop losses. They also produce a variety of mycotoxins, which can have harmful effects on human and animal health.
In humans, Alternaria species can cause allergic reactions, such as hay fever and asthma, as well as skin and respiratory tract infections. Exposure to Alternaria spores is also a known risk factor for the development of allergic bronchopulmonary aspergillosis (ABPA), a condition characterized by inflammation and scarring of the lungs.
It's important to note that medical definitions can vary depending on the context, so it may be helpful to consult a reliable medical or scientific source for more specific information about Alternaria and its potential health effects.
Trichothecenes are a group of chemically related toxic compounds called sesquiterpenoids produced by various species of fungi, particularly those in the genera Fusarium, Myrothecium, Trichoderma, Trichothecium, and Stachybotrys. These toxins can contaminate crops and cause a variety of adverse health effects in humans and animals that consume or come into contact with the contaminated material.
Trichothecenes can be classified into four types (A, B, C, and D) based on their chemical structure. Type A trichothecenes include T-2 toxin and diacetoxyscirpenol, while type B trichothecenes include deoxynivalenol (DON), nivalenol, and 3-acetyldeoxynivalenol.
Exposure to trichothecenes can cause a range of symptoms, including skin irritation, nausea, vomiting, diarrhea, abdominal pain, and immune system suppression. In severe cases, exposure to high levels of these toxins can lead to neurological problems, hemorrhage, and even death.
It is important to note that trichothecenes are not typically considered infectious agents, but rather toxin-producing molds that can contaminate food and other materials. Proper handling, storage, and preparation of food can help reduce the risk of exposure to these toxins.
Fungi, in the context of medical definitions, are a group of eukaryotic organisms that include microorganisms such as yeasts and molds, as well as the more familiar mushrooms. The study of fungi is known as mycology.
Fungi can exist as unicellular organisms or as multicellular filamentous structures called hyphae. They are heterotrophs, which means they obtain their nutrients by decomposing organic matter or by living as parasites on other organisms. Some fungi can cause various diseases in humans, animals, and plants, known as mycoses. These infections range from superficial, localized skin infections to systemic, life-threatening invasive diseases.
Examples of fungal infections include athlete's foot (tinea pedis), ringworm (dermatophytosis), candidiasis (yeast infection), histoplasmosis, coccidioidomycosis, and aspergillosis. Fungal infections can be challenging to treat due to the limited number of antifungal drugs available and the potential for drug resistance.
List of MeSH codes (E05)
Isoniazid
Iron-binding proteins
Bactericidal permeability-increasing protein
Moraxella catarrhalis
Weil-Felix test
Timeline of immunology
Leprostatic agent
Piperacillin
Ernest Hanbury Hankin
Prulifloxacin
Brazilian purpuric fever
Acetylcysteine
Butylparaben
Meningococcal disease
Malcolm Robert Irwin
Gentamicin
Pneumococcal infection
Peptidoglycan recognition protein
Linezolid
Ertapenem
Aflatoxin B1
Antibiotic
Lipopolysaccharide
Colostrum
James Collins (bioengineer)
Polycystic kidney disease
Eosinophil cationic protein
Lactoferrin
Infective endocarditis
Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany - Volume 16, Number 3-March 2010 - Emerging...
Antibiotics | Free Full-Text | Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis...
PDF) Cold exposure: Human immune responses and intracellular cytokine expression
Advanced Search Results - Public Health Image Library(PHIL)
Prevention and Control of Meningococcal Disease
Infective Endocarditis Treatment & Management: Approach Considerations, Antibiotic Therapy, Management of S aureus Bacteremia
Page 1 | Search Results | Acta Haematologica | Karger Publishers
Vaccines | Free Full-Text | Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to...
MoldSTAT Organism Kill List | Cleaner Today
List of MeSH codes (E05) - Wikipedia
Development of Serum Bactericidal Assay for P. aeruginosa, IJSR, Call for Papers, Online Journal
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single...
UK launch for Pfizer's MenB jab Trumenba - PharmaTimes
Annealing Temperature Influences the Cytocompatibility, Bactericidal and Bioactive Properties of Green Synthesised TiO2...
Penicillin G Potassium (Penicillin G Potassium): Uses, Dosage, Side Effects, Interactions, Warning
Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection | BMC...
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children
In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens |...
Value Set Details
Colony Counters | Fisher Scientific
CDC Science Clips
Pesquisa | Portal Regional da BVS
Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in...
Pfizer reports Results From Two Phase 3 TRUMENBA (Meningococcal Group B Vaccine) Studies At The European Society For Paediatric...
HL7.TERMINOLOGY\SusceptibilityObservationMethodType - FHIR v4.0.1
POLYMYXIN B FOR INJECTION500,000 Units
Production of highly immunogenic and safe Triton X-100 produced bacterial ghost vaccine against Shigella flexneri 2b serotype |...
The identification of novel immunogenic antigens as potential Shigella vaccine components | Genome Medicine | Full Text
DailyMed - NAFCILLIN injection, powder, for solution
Tuberculosis (TB) - Infectious Diseases - Merck Manuals Professional Edition
Assays6
- Hyperimmune mouse serum raised against purified, recombinant OmpP4 did not promote bactericidal killing of 35000HP or phagocytosis by J774A.1 mouse macrophages in serum bactericidal and phagocytosis assays, respectively. (biomedcentral.com)
- Immune responses were assessed by serum bactericidal assays using human complement (hSBA). (worldpharmatoday.com)
- Additional specialty assays can be seamlessly accessed through LabCorp including Monogram Biosciences , a member of LabCorp's Specialty Testing Group. (labcorp.com)
- Migration experiments were carried out in Boyden chambers with bacterial chemotactic factor as the attractant, and bactericidal assays were done with Staphylococcus aureus and serum from an AB blood group donor as a source of opsonins. (docksci.com)
- This provides a product that has low heterophile antibody activity for many applications, including use in bactericidal and opsonization assays. (pel-freez.com)
- Suitable for functional antibody assays (SBA-Serum Bactericidal Assay, MOPA/OPA- Multiplexed /Opsonophagocytic Killing Assay) for vaccine evaluation. (pel-freez.com)
Assay using human comp2
- Immunogenicity was determined in serum bactericidal antibody assay using human complement (hSBA) by use of four meningococcal serogroup B test strains expressing vaccine-heterologous factor H binding protein variants: PMB80 (A22), PMB2001 (A56), PMB2948 (B24), and PMB2707 (B44). (nih.gov)
- Immunogenicity was determined by serum bactericidal assay using human complement (hSBA). (bvsalud.org)
Complement3
- Yersinia pestis Δail Mutants Are Not Susceptible to Human Complement Bactericidal Activity in the Flea. (cdc.gov)
- Among identified virulence factors is the attachment invasion locus protein, Ail, that is required to protect Y. pestis from serum complement in all mammals tested except mice. (cdc.gov)
- Six antigens (FepA, EmrK, FhuA, MdtA, NlpB, and CjrA) were identified in in vivo testing as capable of producing binding IgG and complement-mediated bactericidal antibody. (biomedcentral.com)
Antibodies5
- The primary objective of this research work is to develop a serum bactericidal assay (SBA) for the quantification of bactericidal antibodies in human serum for P. aeruginosa (pSBA). (ijsr.net)
- We aimed to assess the persistence of bactericidal antibodies up to 4 years after a three-dose schedule of bivalent rLP2086. (nih.gov)
- In H. influenzae , e (P4) stimulates production of bactericidal and protective antibodies and contributes to pathogenesis by facilitating acquisition of the essential nutrients heme and nicotinamide adenine dinucleotide (NAD). (biomedcentral.com)
- Here, we tested the hypothesis that, like its homolog, H. ducreyi OmpP4 contributes to virulence and stimulates production of bactericidal antibodies. (biomedcentral.com)
- Bactericidal/permeability-increasing protein-anti-neutrophil cytoplasmic antibodies (BPI-ANCA) from people with cystic fibrosis (PwCF) do not recognize orthologous proteins of human BPI (huBPI). (elifesciences.org)
Strains8
- The study was powered to assess immunological interference against pooled serogroup B test strains. (bvsalud.org)
- Immune responses (GMTs and 80% CIs) were lower for PorA and NHBA serogroup B test strains in the MenABCWY group compared to the 4CMenB+ACWY/D group and 4CMenB group. (bvsalud.org)
- MenABCWY vaccination was immunogenic against MenB test strains. (bvsalud.org)
- The importance of this observation is that it identifies a protective niche for the growth of serum sensitive and nonsensitive Y. pestis strains. (cdc.gov)
- The study primary endpoint assessed the percentage of subjects with a response to four primary MnB test strains (N=1210-1266), representative of prevalent MnB strains, and the secondary endpoint assessed responses to 10 additional MnB test strains in a population subset (N=266-281). (worldpharmatoday.com)
- The hSBA responses one month after doses 2 and 3 against the four primary MnB test strains as defined by hSBA responses (titers ≥LLOQ) were 64.0%-99.1% and 87.1%-99.5%, respectively. (worldpharmatoday.com)
- The hSBA responses to the 10 additional MnB test strains were 61.1%-100.0% and 75.1%-98.6% one month after dose 2 and 3, respectively. (worldpharmatoday.com)
- The data demonstrate that TRUMENBA induces protective serum bactericidal antibody responses to diverse MenB test strains that are representative of disease causing strains, and the vaccine has an established safety profile.13 In clinical studies, the most common adverse reactions observed were injection site pain, redness and swelling at the vaccination site, headache, fatigue, chills, diarrhea, muscle pain, joint pain and nausea. (biopharmabusiness.com)
Activity12
- Bactericidal activity in serum samples from the New Zealand MeNZB vaccination campaign confirmed vaccine preventability. (cdc.gov)
- This study demonstrated Anti-pseudomonas functional activity in human serum. (ijsr.net)
- A ≥ 5 log 10 (99.999%) decrease of bacteria and ≥ 4 log 10 (99.99%) reduction in viral titre represented effective bactericidal and virucidal activity, respectively, per European standards. (springer.com)
- PVP-I gargle/mouthwash diluted 1:30 (equivalent to a concentration of 0.23% PVP-I) showed effective bactericidal activity against Klebsiella pneumoniae and Streptococcus pneumoniae and rapidly inactivated SARS-CoV, MERS-CoV, influenza virus A (H1N1) and rotavirus after 15 s of exposure. (springer.com)
- PVP-I 7% gargle/mouthwash showed rapid bactericidal activity and virucidal efficacy in vitro at a concentration of 0.23% PVP-I and may provide a protective oropharyngeal hygiene measure for individuals at high risk of exposure to oral and respiratory pathogens. (springer.com)
- Human sera retained bactericidal activity against a Y. pestis ail mutant in the presence of mouse sera. (cdc.gov)
- This indicated that Ail activity was somehow blocked, most likely by lipooligosaccharide, in this serum sensitive strain. (cdc.gov)
- Since the drug loses 50 percent of its activity in the presence of serum, active blood levels are low. (nih.gov)
- Immunized mice sera showed a significant increase in serum bactericidal activity of both preparations (TX100 = 40% and TW80 = 56%) compared to the non-immunized challenged group (positive control). (biomedcentral.com)
- Bactericidal activity was suppressed by acetylsalicylic acid, sodium salicylate and phenacetin. (docksci.com)
- The amino acid sequence mediating the bactericidal activity of human BPI (huBPI) is underlined. (elifesciences.org)
- Department of Physiology at Vidyasagar activity of neutrophils was greater in the College for Women in Kolkata for testing. (who.int)
Bovine4
- PVP-I 7% gargle/mouthwash was diluted 1:30 with water to a concentration of 0.23% (the recommended concentration for "real-life" use in Japan) and tested at room temperature under clean conditions [0.3 g/l bovine serum albumin (BSA), viruses only] and dirty conditions (3.0 g/l BSA + 3.0 ml/l erythrocytes) as an interfering substance for defined contact times (minimum 15 s). (springer.com)
- and F. psychrophilum were conserved at −80°C in 1 ml skimmed milk (Becton Dickinson, Switzerland) supplemented with 10% bovine serum and 20% glycerol. (trpvantagonists.com)
- The cells were isolated by a method previously described7 and then suspended in KrebsRinger phosphate (KRP) solution, pH 7.45, to which was added 0.006 M glucose and 0.35% bovine serum albumin (Sigma Chemicals, St. Louis, Missouri). (docksci.com)
- We determined the minimum bactericidal concentration (MBC) by incubating strain suspensions in Brucella broth with fetal bovine serum and samples at different concentrations in a final volume of 100 microl in a microaerobic atmosphere. (lacienciadelvino.com)
Strain4
- 1 month after the third vaccination, 93% (n=139/149) to 100% (n=48/48) of vaccine recipients achieved protective hSBA titres equal to or greater than the lower limit of quantification to each test strain, compared with 0% (n=0/25) to 35% (n=8/23) of control recipients. (nih.gov)
- PVP-I was tested against Klebsiella pneumoniae and Streptococcus pneumoniae according to bactericidal quantitative suspension test EN13727 and against severe acute respiratory syndrome and Middle East respiratory syndrome coronaviruses (SARS-CoV and MERS-CoV), rotavirus strain Wa and influenza virus A subtype H1N1 according to virucidal quantitative suspension test EN14476. (springer.com)
- Susceptibility plate testing: If the Kirby-Bauer method of disc susceptibility testing is used, a 300-unit polymyxin B disc should give a zone of over 11 mm when tested against a polymyxin B susceptible bacterial strain. (nih.gov)
- In the bactericidal experiments, a hospital strain of Staphylococcus aureus was grown overnight in trypticase soy yeast broth (Difco Laboratories), separated by centrifugation, washed and resuspended in 0.9% sodium chloride to approximately 5.0 x l0. (docksci.com)
Minimum inhibitory co1
- The bactericidal properties were determined via the minimum inhibitory concentration (MIC) and Kirby-Bauer disc diffusion methods. (researchsquare.com)
Vitro4
- We investigated the in vitro bactericidal and virucidal efficacy of povidone-iodine (PVP-I) 7% gargle/mouthwash at defined dilution against oral and respiratory tract pathogens. (springer.com)
- Rat or human but not mouse sera were bactericidal against a Y. pestis ail mutant at 28C in vitro. (cdc.gov)
- These were deleted, and the mutants were tested for correlates of virulence in vitro and in vivo. (hal.science)
- In vitro tests demonstrate that the cephalosporins are bactericidal because of their inhibition of cell-wall synthesis. (druglib.com)
Susceptible2
- A report of "Intermediate" indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. (druglib.com)
- This drug is indicated in the treatment of moderately severe infections due to penicillin-G-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. (pfizermedicalinformation.com)
Susceptibility tests1
- Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. (rxlist.com)
Homologous3
- The homologous reactions, which determined the type, afforded the major protection and developed promptly and regularly in the serum of rabbits during immunization. (silverchair.com)
- The associated cross-reactions, on the other hand, appeared in the serum of certain rabbits only, were often not as strong as the associated homologous reactions, and required for their presence a longer period of immunization than the homologous reactions. (silverchair.com)
- Agar gel analysis of the homologous precipitin reactions revealed, as would be expected, reactions of serological identity, while those cross-reactions which were strong enough to test in this way formed bands of precipitate which joined with spur formation on the side of the homologous reaction. (silverchair.com)
Bacteriostatic1
- 1. Explain the difference between the actions of bacteriostatic and bacteriocidal drugs. (nursingcapstoneproject.com)
Isolates3
- Cross-reactivity definition - An antigenic variant was considered cross-reactive if it had been tested in ≥5 isolates/subjects and was above the accepted threshold in ≥75% of those isolates. (pubmlst.org)
- In the present work, we tested the antioxidant and antimicrobial activities of hydro-alcoholic extracts from Colorino, Sangiovese and Cabernet Sauvignon grape cultivars against H. pylori G21 (cagA-negative, cagA-) and 10K, (cagApositive, cagA+) clinical isolates. (lacienciadelvino.com)
- Reports have been limited to antimicrobial susceptibility test results of clinical isolates, usually from reference laboratories, animal studies and case summaries ( 19 , 78 ). (antimicrobe.org)
Protective1
- However, in the flea vector, the serum protective properties of Ail were not required. (cdc.gov)
Titre1
- No major variations in pSBA titre with different bacterial inoculum tested. (ijsr.net)
Microorganisms2
- Penicillin G exerts a bactericidal action against penicillin-sensitive microorganisms during the stage of active multiplication. (pediatriconcall.com)
- Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). (bvsalud.org)
Humans3
- To test whether OmpP4 was necessary for virulence in humans, eight healthy adults were experimentally infected. (biomedcentral.com)
- Ail confers serum resistance in humans and is a critical virulence factor of Y. pestis, the causative agent of plague. (cdc.gov)
- In this study, we asked, is bactericidal sera from humans active in Y. pestis colonized fleas We found it was not. (cdc.gov)
Functional1
- Annealing is a crucial functional parameter relevant to the green synthesis and bactericidal properties of TiO 2 nanocomposites (TiO 2 -NPs). (researchsquare.com)
Proteins2
- Nafcillin binds to serum proteins, mainly albumin. (nih.gov)
- Sequence alignment and analysis of orthologous proteins to human bactericidal/permeability-increasing protein (huBPI). (elifesciences.org)
Resistance4
- This could be due to mechanisms simply not tested for or intrinsic resistance to a given antibiotic. (medscape.com)
- If molecular blood testing is not available, the initial antibiotic choice is arrived at by SA and attention to local resistance patterns. (medscape.com)
- Similarly, flea studies with human blood showed Ail was not required for serum resistance. (cdc.gov)
- None of the deleted mutants was modified in its resistance to the bactericidal effect of serum. (hal.science)
Efficacy1
- Efficacy of Echinacea-Supplemented Feeding on Health and Immune Status of Horses Phytotherapeutic medication with immunemodulatory efficacy represent one possible alternative to general bactericidal or anti-inflammatory agents. (uni-muenchen.de)
Concentration1
- General well-being, blood results, the plasma cortisol concentration as well as the serum concentration of immune globuline G were determined on Day 0, 10, 21, 28, 35, and 70. (uni-muenchen.de)
Pathogens1
- BACKGROUND: Telavancin is a lipoglycopeptide bactericidal against gram-positive pathogens. (duke.edu)
Systemic1
- The relative likelihood of sepsis versus noninfectious systemic inflammation was found to increase with increasing test score (range, 0-10). (tropmedres.ac)
Bacterial2
- Flea colonization studies using murine sera and Y. pestis KIM6(+) wild type, a ail mutant, and the ail/ail(+) control showed no differences in bacterial prevalence or numbers during the early stage of flea colonization. (cdc.gov)
- both bacterial ghost vaccines (BGVs) were safe and effective, according to the results of the safety check tests and histopathological analysis. (biomedcentral.com)
Virulence1
- N. farcinica is particularly important to distinguish since it has increased virulence and differs in its antimicrobial susceptibility test results and its epidemiology ( 16 , 126 ). (antimicrobe.org)
Human1
- Finally, a variant of Ail (Ail(F100V E108_S109insS)) from a human serum-sensitive Y. pestis subsp. (cdc.gov)
Acute2
- These antigens were expressed and probed with acute and convalescent serum from microbiologically confirmed Shigella infections. (biomedcentral.com)
- However, a higher rate of acute toxicity (severe cutaneous toxicity and need for nutritional support) was found for RT-Cx, with 11% of harmful death and 13% of discontinuation rate of RT 0% of CRT group (33.3%, 15.1%) were detected.51 Recently, two randomized phase?III tests, RTOG 1016 and De-ESCALaTE, investigated the substitution of cisplatin with Cx in individuals with advanced HPV? (siamtech.net)
Clinical2
- Therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. (pfizermedicalinformation.com)
- The primary end point was clinical response at follow-up/test-of-cure visit. (duke.edu)
Immune1
- When comparing the BGVs prepared using TX100 and TW80 methods, the use of TX100 as a new chemical treating agent for BGC production attained robust results in terms of shorter incubation time with the targeted cells and a strong immune response against S. flexneri 2b serotype ATCC 12022 in the IP challenge test. (biomedcentral.com)
Inconspicuous area2
- For plastic and painted surfaces, spot test on an inconspicuous area before use. (drugs.com)
- Test a small inconspicuous area first. (thebestpetshampoo.com)
Penicillin3
- Tetracycline: May antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. (pediatriconcall.com)
- Laboratory Tests: In prolonged therapy with penicillin and particularly with high-dosage schedules, periodic evaluation of the renal and hematopoietic systems is recommended. (pediatriconcall.com)
- When high, sustained serum levels are required, penicillin G sodium or potassium, either IM or IV, should be used. (pfizermedicalinformation.com)
Effect2
- In this work, the effect of the annealing temperature on the physicochemical and bactericidal properties of TiO 2 -NPs obtained from Calotropis gigantea was comprehensively studied. (researchsquare.com)
- The transformed protein effort may test Chief to boiling of the moderate women( other diabetes), to life by a heart( many Effect), or less generally, to be receptor of mixtures and Recent electrical arteries within the interest. (augenta.net)
Dilution1
- At 4 ounces per gallon of water or equivalent dilution, this product inactivates Canine Parvovirus on hard, non-porous, environmental surfaces in the presence of 5% blood serum with a 10-minute contact time. (thebestpetshampoo.com)
Results1
- Determination of immuneglobuline G fostered serum results between 17.15 mg/ml and 26.82 mg/ml. (uni-muenchen.de)
Antigens1
- isolate contains antigens for which there is insufficient data from or are yet to be tested in experimental studies. (pubmlst.org)
Levels1
- At least 1 of the prescribed agents must be documented to achieve bactericidal levels when taken by mouth. (medscape.com)
Regimen1
- Geranium Oil can easily become part of your everyday skincare regimen by adding it to a serum or moisturizer for your face, as it pairs perfectly with Lavender, Tangerine , and Ylang Ylang essential oils to provide an uplifting floral aroma and make your face glow. (mokshalifestyle.com)
Influence1
- It was not possible to determine a positive or negative influence of Echinacea-supplemented feeding on any of the discussed parameters under this test conditions (typical horse keeping conditions, placebo-controlled double blind study). (uni-muenchen.de)
Methods1
- Description:**Test methods designed to determine a microorganism’s susceptibility to an antibiotic. (hl7.org)
Sodium1
- The plant-mediated nano-sized cubic and spherical anatase TiO 2 -NPs encapsulated bioactive green elements, such as carbon, sodium, magnesium, chlorine, potassium, calcium and sulphur, from the C . gigantea extract, ultimately leading to versatile and eco-friendly bactericidal agents with wound-healing properties. (researchsquare.com)
Study1
- An additional group of 198 patients, recruited in the large MARS (Molecular Diagnosis and Risk Stratification of Sepsis) consortium trial in the Netherlands ( www.clinicaltrials.gov identifier NCT01905033), was also tested and analyzed, making a grand total of 447 patients in our study. (tropmedres.ac)